SEC Form 4 · accession 0001144204-15-055254
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ming Yang
Officer — Chief Financial Officer
Period of report
Sep 14, 2015
Accepted (ET)
Sep 16, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Sep 14, 2015 | M | 1,000 | $9.85 | A | 36,086 | D | |
| Common stockF2,F4 | Sep 14, 2015 | S | 11,304 | $97.08 | D | 24,782 | D | |
| Common stockF3 | Sep 15, 2015 | M | 9,000 | $9.85 | A | 33,782 | D | |
| Common stockF3,F5 | Sep 15, 2015 | S | 9,000 | $94.56 | D | 24,782 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6,F8 | $9.85 | Sep 14, 2015 | M | 1,000 | D | Sep 1, 2013 | Aug 31, 2022 | Common stock | 1,000 | 49,000 | D |
| Stock Option (right to buy)F7,F8 | $9.85 | Sep 15, 2015 | M | 9,000 | D | Sep 1, 2013 | Aug 31, 2022 | Common stock | 9,000 | 40,000 | D |
Explanation of responses
- F1Represents 1,000 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 6 below for further details on the relevant stock options.
- F2Represents 11,304 shares of common stock (the "September 14 Sold Common Stock") sold on the open market at a weighted average price of $97.08 per share on September 14, 2015. The September 14 Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase 1,000 shares of the Issuer's common stock and vesting of 10,304 restricted stocks.
- F3Represents 9,000 shares of common stock (the "September 15 Sold Common Stock") sold on the open market at a weighted average price of $94.56 per share on September 15, 2015. The September 15 Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase 9,000 shares of the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $93.70 to $100.50, inclusive. The Reporting Person undertakes to provide to any security holders of China Biologic Products, Inc. (the "Issuer") or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 4 and Footnote 5 to this Form 4.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $94.00 to $95.54, inclusive.
- F6Represents previously reported stock options to purchase 1,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
- F7Represents previously reported stock options to purchase 9,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
- F8Includes the balance of the previously reported stock options to purchase 50,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012.